Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation | Zendy

Chao Liu | Zendy; Sayed H. Sadat | Zendy; Koji Ebisumoto | Zendy; Akihiro Sakai | Zendy; Bharat Panuganti | Zendy; Shuling Ren | Zendy; Yusuke Goto | Zendy; Sunny Haft | Zendy; Takahito Fukusumi | Zendy; Mizuo Ando | Zendy; Yuki Saito | Zendy; Theresa Guo | Zendy; Pablo Tamayo | Zendy; Huwate Yeerna | Zendy; William Kim | Zendy; Jacqueline A. Hubbard | Zendy; Andrew B. Sharabi | Zendy; J. Silvio Gutkind | Zendy; Joseph A. Califano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation

Author(s) -

Chao Liu,

Sayed H. Sadat,

Koji Ebisumoto,

Akihiro Sakai,

Bharat Panuganti,

Shuling Ren,

Yusuke Goto,

Sunny Haft,

Takahito Fukusumi,

Mizuo Ando,

Yuki Saito,

Theresa Guo,

Pablo Tamayo,

Huwate Yeerna,

William Kim,

Jacqueline A. Hubbard,

Andrew B. Sharabi,

J. Silvio Gutkind,

Joseph A. Califano

Publication year - 2020

Publication title -

clinical cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.427

H-Index - 324

eISSN - 1557-3265

pISSN - 1078-0432

DOI - 10.1158/1078-0432.ccr-18-3301

Subject(s) - head and neck squamous cell carcinoma , cancer research , gene knockdown , cannabinoid receptor , mapk/erk pathway , cell growth , small hairpin rna , cannabinoid , apoptosis , biology , cancer , medicine , oncology , head and neck cancer , receptor , signal transduction , antagonist , microbiology and biotechnology , genetics

Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) is associated with daily marijuana use and is also increasing in parallel with increased marijuana use in the United States. Our study is designed to define the interaction between cannabinoids and HPV-positive HNSCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research